Skip to content

Hysteroscopic Assessment of Fallopian Tubal Patency

Hysteroscopic Assessment of Fallopian Tubal Patency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02005263
Enrollment
621
Registered
2013-12-09
Start date
2013-12-31
Completion date
2017-11-06
Last updated
2017-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Menorrhagia

Keywords

Hysteroscopy

Brief summary

Disease of the fallopian tubes is one of the most common reasons for infertility. The most common test, a hysterosalpingogram, tends to be painful,inconvenient, and frequently misses concurrent uterine disease. We propose using a less painful technique (through modified office hysteroscopy) for tubal assessment that can be performed in the office rather than hospital radiology and that uses gold standard technology for identifying coexisting uterine conditions.

Interventions

PROCEDURESalpingography

Infusion of typically 1-2 mL of air bubbles in to the uterine cavity to assess whether they disappear through the ostia in to the Fallopian tubes.

Sponsors

University of Mississippi Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. 18 - 50 years old 2. Able to give consent 3. Must have a uterus 4. Must have documented negative testing for gonorrhea and chlamydia within the past year or previously negative when tested with a current partner in a monogamous relationship 5. Negative test prior to procedure

Exclusion criteria

1. Pregnancy 2. Active lower and upper genital tract infection 3. Patients with allergies to hysterosalpingogram contrast will not be exposed to a contrast material to which they are allergic 4. Premenarchal or postmenopausal 5. Unable to read English at a 6th grade level or above 6. History of endometrial Ablation 7. Asherman's syndrome \> Stage 1

Design outcomes

Primary

MeasureTime frameDescription
Hysteroscopic assessment of tubal patency2 yearsPatients undergoing the procedure will be informed based on the findings as to whether or not it is believed that their Fallopian tubes are patent

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026